6-BROMO-4-METHOXY-1H-INDOLE-3-CARBALDEHYDE, 97.0%, 250mg

1-(5-Nitroindolin-1-yl)ethanone, 95.0%, 1g

3-chloro-6,7-dihydro-5H-cyclopenta[c]pyridazine, 95.0%, 500mg

Etiketten Tough Spots auf der Rolle rund, weiß, 9,5 mm, Gesch. für 0,5-ml-Fläschchen, 1 Rolle

N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-phenylacetamide, 97.0%, 25g

4-Bromopicolinamide, 95.0%, 1g

2-(Methoxymethyl)-1,3-thiazole-5-carboxylic acid, 95%, 50mg

4-iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole, 95.0%, 5g

[6-(Trifluoromethyl)pyridin-3-yl]methanol>98.0%(GC)250mg

Ethyl p-Tolylacetate>98.0%(GC)5g

2-(TERT-BUTOXYCARBONYLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID, 95.0%, 1g

6-AMINO-1,3-DIMETHYL-1,2,3,4-TETRAHYDROQUINAZOLIN-2-ONE, 95.0%, 250mg

1-(Aminomethyl)-n,n-dimethylcyclobutan-1-amine, 98+%, 1g